SCHEMBL28267166

SCHEMBL28267166

NCc1c(Cl)cccc1-c1cc(NCCc2ccc(S(N)(=O)=O)cc2)nc(N)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 12/20 0.49
CA2 P00918 12/20 0.49
CA9 Q16790 11/20 0.49
CA12 O43570 5/20 0.46
CA14 Q9ULX7 4/20 0.46
MRGPRX1 Q96LB2 2/20 0.45
KCNH2 Q12809 1/20 0.44
PTGDR Q13258 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA7 P43166 2/20 0.41
CA13 Q8N1Q1 2/20 0.41
CA3 P07451 1/20 0.41
NUDT1 P36639 1/20 0.41
CA5A P35218 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17315485 0.91 CA2 (0.48) CA1CA2CA9CA12CA14
SCHEMBL15757085 0.89 NUDT1 (0.54) CA1CA2CA9CA12CA14
SCHEMBL28267613 0.89 CA1 (0.49) CA1CA2CA9CA12CA14
SCHEMBL15757994 0.87 CA1 (0.50) CA1CA2CA9CA12CA14
SCHEMBL28267162 0.86 CA2 (0.47) CA1CA2CA9CA12CA14
SCHEMBL17315550 0.83 CA1 (0.50) CA1CA2CA9CA12CA14
SCHEMBL17315157 0.83 ALDH1A1 (0.43) CA1CA2CA9CA12CA14
SCHEMBL17315292 0.82 CA1 (0.53) CA1CA2CA9CA12CA14
SCHEMBL28265697 0.82 CA1 (0.50) CA1CA2CA9CA12CA14
SCHEMBL28265870 0.82 MRGPRX1 (0.53) CA1CA2CA9CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN claimed
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed